Resmed (RMD) Share-based Compensation Growth (1y) (2010 - 2026)
Powered by 
Analysis
Resmed (RMD) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 18.31% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 314.20% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 45.35% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | -78.13% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | -15.28% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 12.53% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | -13.91% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 10.94% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 10.53% |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 7.56% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.94% |
| Mar 31, 2026 | 11.08% |
| Dec 31, 2025 | 27.85% |
| Sep 30, 2025 | 4.98% |
| Jun 30, 2025 | 15.70% |
| Mar 31, 2025 | 17.99% |
| Dec 31, 2024 | 14.08% |
| Sep 30, 2024 | 8.89% |
| Jun 30, 2024 | 7.35% |
| Mar 31, 2024 | 14.64% |
| Dec 31, 2023 | 20.51% |
| Sep 30, 2023 | 9.40% |
| Jun 30, 2023 | 53.53% |
| Mar 31, 2023 | 691.48% |
| Dec 31, 2022 | 2.25% |
| Sep 30, 2022 | -2.22% |
| Jun 30, 2022 | -7.22% |
| Mar 31, 2022 | -85.55% |
| Dec 31, 2021 | 4.76% |
| Sep 30, 2021 | 7.67% |